Novel Antimicrobials for the Treatment of <i>Clostridium difficile</i> Infection.

Front Med (Lausanne) · 2018 · PMC5911476 · PMID 29713630

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Even if similar clinical cure rates at the end of treatment (77% for nitazoxanide and 74% for vancomycin) and recurrence rates (5% for nitazoxanide and 7% for vancomycin) were observed, these results did not reach statistical significance ( 40 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.